The role of MRI in pharmacovigilance of natalizumab-treated MS patients: a “known unknown”?

Research output: ThesisResearch VU University Amsterdam, graduation VU University Amsterdam

Original languageEnglish
QualificationDoctor of Philosophy
Awarding Institution
  • Vrije Universiteit Amsterdam, Netherlands
Supervisors/Advisors
  • Barkhof, Frederik, Supervisor
  • Uitdehaag, Bernard, Supervisor
  • Killestein, Joep, Supervisor
Award date3 Jun 2019
Publication statusPublished - 2019

Cite this